Efficacy and Safety in the Continued Treatment With a Biosimilar Drug in Patients Receiving Infliximab: A Systematic Review in the Context of Decision-Making From a Latin-American Country-Reference-Cited by-同舟云学术

Efficacy and Safety in the Continued Treatment With a Biosimilar Drug in Patients Receiving Infliximab: A Systematic Review in the Context of Decision-Making From a Latin-American Country

Published:2019-11-15 Issue: Volume:10 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Mezones-Holguin Edward,Gamboa-Cardenas Rocio Violeta,Sanchez-Felix Gadwyn,Chávez-Corrales José,Helguero-Santin Luis Miguel,Laban Seminario Luis Max,Burela-Prado Paula Alejandra,Castro-Reyes Maribel Marilu,Fiestas Fabian

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference70 articles.

1. A systematic review of the use of quality-of-life instruments in randomized controlled trials for psoriasis;Ali;Br. J. Dermatol.,2017

2. Subgroup analysis and other (mis)uses of baseline data in clinical trials;Assmann;The Lancet,2000

3. Regulatory Convergence for biologics through capacity building and training;Auclair;Trends Biotechnol.,2019

4. The burden of common skin diseases assessed with the EQ5DTM: a European multicentre study in 13 countries;Balieva;Br. J. Dermatol.,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study;RMD Open;2023-03

2. The Safety and Effectiveness of Infliximab Biosimilar in Managing Rheumatoid Arthritis: A Real-Life Experience from Jordan;International Journal of Clinical Practice;2022-08-26

3. Pharmacoeconomic rationale for switching patients with rheumatic diseases from original biologic disease-modifying antirheumatic drugs to biosimilars in context of the Russian healthcare system;Modern Rheumatology Journal;2022-06-29

4. TNF-α levels and presence of SNP-308G/A of TNF-α gene in temporomandibular disorder patients;Dental Press Journal of Orthodontics;2022

5. Infliximab switching from reference product to biosimilar: a review of evidence regarding the clinical efficacy, safety profile and immunogenicity;Journal of Pharmacy Practice and Research;2021-10